Using Stress Proteins to Help the Body Accept Organ Transplants

A method for preventing organ transplant rejection by using stress proteins to teach the immune system to tolerate donor tissue.

What it covers

This patent describes a way to stop the body from attacking a transplanted organ by using stress proteins. These proteins are naturally occurring molecules that act like a delivery system; when bound to specific antigens from the donor organ, they can be introduced to the recipient's immune system. By presenting these donor-specific markers to immune cells, the treatment aims to modulate the immune response, essentially training the body to accept the graft instead of rejecting it. The process can involve treating cells outside the body or administering the protein-antigen complex directly to the patient.

What it doesn't cover

• —Does not cover general protection against cell death or mortality.
• —Does not cover non-specific immune suppression methods like traditional steroids.
• —Does not cover the use of stress proteins without an attached donor-specific antigen.
• —Does not cover surgical techniques for performing the actual transplant.

The clever bit

The innovation lies in using the stress protein's natural ability to bind and carry peptides to act as a chaperone, delivering the donor's specific identity markers to the immune system in a way that induces tolerance rather than an attack.

Why it matters

Organ rejection remains a primary hurdle in transplantation, requiring patients to take lifelong immunosuppressants that leave them vulnerable to infection. This patent proposed a more targeted, biological approach to create immune tolerance, which is the holy grail of transplant medicine. It represents an early attempt to harness the body's own protein machinery to solve the rejection problem.

Real-world examples

• 1.Experimental immunotherapy for organ transplantation
• 2.Research into antigen-specific tolerance induction